Liu M.D., Ph.D., Runhua

Liu M.D., Ph.D., Runhua
Assistant Professor

Member, Cancer Cell Biology , Comprehensive Cancer Center
Assistant Professor (P), Genetics Research Division , Genetics Chair Office 2012 -
Associate Scientist (C), Comprehensive Cancer Center , School of Medicine 2013 -

Selected Publications

Academic Article

Year	Title	Altmetric
2019	MicroRNA-1205, encoded on chromosome 8q24, targets EGLN3 to induce cell growth and contributes to risk of castration-resistant prostate cancer 2019
2019	Loss of FOXP3 and TSC1 accelerates prostate cancer progression through synergistic transcriptional and posttranslational regulation of c-Myc 2019
2018	FOXP3 activates SUMO-conjugating UBC9 gene in MCF7 breast cancer cells 2018
2017	MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer 2017
2017	Jun dimerization protein 2 activates Mc2r transcriptional activity: Role of phosphorylation and SUMOylation 2017
2016	Silencing of CD24 enhances the PRIMA-1-induced restoration of mutant p53 in prostate cancer cells 2016
2015	FOXP3 controls an MIR-146/NF-κB negative feedback loop that inhibits apoptosis in breast cancer cells 2015
2015	FOXP3-MIR-146-NF-κB axis and therapy for precancerous lesions in prostate 2015
2014	SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells 2014

Principal Investigator On

Effects of CD24-RCC2 Signaling on Prostate Cancer Metastasis awarded by DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY 2015 - 2019

Investigator On

3/3 Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership awarded by National Cancer Institute/NIH/DHHS 2016 - 2021

Morehouse School of Medicine/Tuskegee University/University of Alabama Cancer Center Partnership: Project 1: CD24-Dependent Inactivation of Mutant p53 in Metastatic Castration-Resistant Prostate Cancer awarded by National Cancer Institute/NIH/DHHS 2016 - 2021

Epigenome Editing for Targeted Reactivation of X- Linked FOXP3 to Treat Breast Cancers awarded by DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY 2017 - 2019

Synergistic Action of FOXP3 and TSC1 Pathways During Tumor Progression awarded by DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY 2014 - 2018

Roles of Semaphorin Signaling in Breast Cancer Racial Disparities awarded by National Cancer Institute/NIH/DHHS 2015 - 2018

MicroRNAs for Monitoring Tumor Progression and Predicting Response to Therapy awarded by National Cancer Institute/NIH/DHHS 2014 - 2017

FOXP3-microRNA146-NFkB Axis in Tumor Suppression awarded by National Cancer Institute/NIH/DHHS 2012 - 2015

Teaching Activities

GBSC718 - Epigenetics (Spring Term 2019) 2019

GGSC320 - Colloquium-Genetics/Genomics (Fall Term 2018) 2018

GBSC718 - Epigenetics (Spring Term 2018) 2018

GBSC718 - Epigenetics (Summer Term 2017) 2017

Education And Training

Doctor of Philosophy Level Degree in Medical Genetics, 2002

Full Name

Runhua Liu